摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1186079-92-4

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1186079-92-4
化学式
C20H28N4O5
mdl
——
分子量
404.466
InChiKey
OMMARLQDWAZSAR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.45
  • 重原子数:
    29.0
  • 可旋转键数:
    5.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.55
  • 拓扑面积:
    98.95
  • 氢给体数:
    1.0
  • 氢受体数:
    8.0

反应信息

  • 作为反应物:
    描述:
    、 alkaline earth salt of/the/ methylsulfuric acid 在 sodium hydride 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成
    参考文献:
    名称:
    Optimization of a series of 2,4-diaminopyridines as neuropeptide Y Y1 receptor antagonists with reduced hERG activity
    摘要:
    The synthesis and evaluation of a series of 2,4-diaminopyridine-based neuropeptide Y Y1 ( NPY Y1) receptor antagonists are described. Compound 1 was previously reported by our laboratory to be a potent and selective Y1 antagonist; however, 1 was also found to have potent hERG inhibitory activity. The main focus of this communication is structure-activity relationship development aimed at eliminating the hERG activity of 1. This resulted in the identification of compound 3d as a potent and selective NPY Y1 antagonist with reduced hERG liability. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.05.069
  • 作为产物:
    描述:
    2-Chlor-4.5-dimethyl-oxazol 、 tert-butyl N-(6-hydroxymethyl-4-morpholino-pyridin-2-yl)carbamate 在 sodium hydride 作用下, 以 四氢呋喃 为溶剂, 以55%的产率得到
    参考文献:
    名称:
    Optimization of a series of 2,4-diaminopyridines as neuropeptide Y Y1 receptor antagonists with reduced hERG activity
    摘要:
    The synthesis and evaluation of a series of 2,4-diaminopyridine-based neuropeptide Y Y1 ( NPY Y1) receptor antagonists are described. Compound 1 was previously reported by our laboratory to be a potent and selective Y1 antagonist; however, 1 was also found to have potent hERG inhibitory activity. The main focus of this communication is structure-activity relationship development aimed at eliminating the hERG activity of 1. This resulted in the identification of compound 3d as a potent and selective NPY Y1 antagonist with reduced hERG liability. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2009.05.069
点击查看最新优质反应信息